Skip to content

Inspection Record

Dr. Reddy's Laboratories Ltd. — FDA 483 Findings

US FDAInspected 2026-06-25Published 2026-11-13 3 findingsAseptic processing and sterility assuranceContamination control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Aseptic processing environmental monitoring procedures are inadequate in them filling line.

2Contamination control

Thewe drug substance manufacturing process lacks adequate controls to prevent microbial contamination of in-process intermediates.

3Aseptic processing and sterility assurance

Your firm failed to ensure that operators working in aseptic manufacturing areas are adequately trained, as evidenced by deficient On-the-Job Training (OJT) records for personnel in them@ _ area.

A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Dr. Reddy's Laboratories Ltd. findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.